1)Intrahepatic metastasis肝内转移
1.Two reasons for that includeintrahepatic metastasis (IM) and multiplecentric occurrence (MO).研究目的探讨多发肝癌在多中心发生和肝内转移方面的发病情况和鉴别两种类型肝癌的理想方法。
2.Multiple and recurrent HCCs are mainly caused by intrahepatic metastasis (IM) known as developing from the same tumor or multicentric occurrence (MO) also known as multicentric carcinogenesis, which is independent from the primary tumor.多结节性肝细胞癌和术后复发性肝细胞癌克隆起源方式可分为肝内转移(intrahepatic metastasis,IM)和多中心发生(multicentric occurrence,MO)两种情况,前者属于单克隆起源,而后者为多克隆起源。
3.Multinolular and intrahepatic recurrent HCC can originate from intrahepatic metastasis and multiple origins,and their colnal origin is closely related to the clinical diagnosis and treatment.多结节和复发性肝细胞癌可分为肝内转移和多中心发生两种,其克隆起源方式与临床诊治密切相关,根据其克隆起源方式设计合理的治疗方案是肝脏外科亟待解决的新问题。
英文短句/例句
1.Huge primary hepatic neuroendocrine carcinoma with multiple metastases: report of one case肝脏巨大神经内分泌癌伴肝内转移1例
2.Study on the Differences of Clinicopathologic Data and Molecular Genetics between Multicentric Occurrence and Intrahepatic Metastasis of Hepatocellular Carcinoma;肝癌多中心发生与肝内转移的临床病理和分子遗传学差异研究
3.Study on the Correlation between Angiogenesis and Intrahepatic Metastasis and PVTT in Hepatocellular Carcinoma;血管生成与肝细胞癌肝内转移和门静脉瘤栓形成的相关性研究
4.Different Analysis Protein Profile of Multicentric Occurrence and Intrahepatic Metastasis of Multinodular HCC肝内转移和多中心发生的多结节肝癌蛋白质表达谱的差异分析及差异蛋白的表达验证
5.Advancement in Liver Transplantation for Hepatic Metastasis from Neuroendocrine Tumor应用肝移植治疗神经内分泌肿瘤肝转移的新进展
6.~(18)F-FDG PET/CT imaging of neuroendocrine tumor of the small intestine with hepatic multiple metastases:case report小肠神经内分泌肿瘤伴肝内多发转移~(18)F-FDG PET/CT显像1例
7.The imageology diagnosis on recurrence and metastasis of primary liver cancer after liver transplantation肝癌肝移植术后复发转移的影像诊断
8.Direct Injection with Absolute Alcohol into Liver Metastasis of Gastric Cancer应用纯酒精(>99.5%)经腹腔内直接注射胃癌肝转移(附7例分析)
9.Inhibition of Metastasis and Angiogenesis of Hepatocellular Carcinoma Cells via Targeting RhoC in Vitro and Vivo;RhoC调控肝细胞癌侵袭转移和新生血管生成的体内外研究
10.Research on Oncolytic Adenovirus Mediated Gene Therapy of Hepatocellular Carcinoma and Metastatic Tumor in Vitro and in Vivo;裂解型腺病毒基因治疗人肝癌细胞及其转移瘤的体内外实验研究
11.Study on Heterogeneity of Vascular Endothelium, Its Potential on Prediction and Intervention of Metastatic Recurrence for Hepatocellular Carcinoma;利用血管内皮异质性预测和干预肝癌转移复发的研究
12.Treatment for Colorectal Cancer Liver Metastasis by AAV-HGFK1 or Combination with 5-fu in Vitro and in Vivo.;AAV-HGFK1或联合5-氟尿嘧啶治疗大肠癌肝转移的体内外实验
13.Function of CD147 in Murine Hepatocarcinoma Hca-F and Hca-P Cells Lymphatic Metastasis in Vivo;CD147在小鼠肝癌细胞Hca-F、Hca-P淋巴道转移中作用的体内研究
14.The Experimental Study of Intro-radioembolization by Portal Vein Infusing Phosphorus-32 Glass Microsphere for Rabbit VX_2 Hepatic Metastatic Carcinoma;~(32)磷玻璃微球门静脉灌注内放射治疗兔肝VX2转移瘤的实验研究
15.A Study on the Angiogenesis and Detection of Micrometastases in Syrian Hamster Intrahepatic Cholangiocarcinoma Carcinogenesis;金仓鼠肝内胆管癌的血管生成与微转移的相关性研究
16.The establishment of stepwise metastatic colorectal carcinoma cell model to the liver via in vivo selection体内连续筛选法建立人结肠癌肝转移阶梯细胞模型
17.p53 Gene Intra-tumor Injection Combined with Bronchial Arterial Infusion Chemotherapy in 18 Cases with Pulmonary Metastatic Liver Cancerp53基因瘤内注射联合支气管动脉灌注化疗治疗18例肝癌肺转移瘤
18.Analysis of the correlation between the number of scattering tumor cells in peritoneal cavity during operation with liver cancer and the incidence of the postoperative seeding metastasis肝癌术中腹腔内游离癌细胞与术后种植转移的相关性分析
相关短句/例句
liver metastasis肝转移
1.Effects of Shengmai injection combined with Oxaliplatin in treatment of liver metastasis from colon cancer;生脉注射液联合奥沙利铂抗结肠癌肝转移的作用
2.Relationships of VEGF and microvessel density with liver metastasis in human colorectal cancer;VEGF和微血管密度与大肠癌肝转移的关系
3.Proteomic analysis of differentially expressed proteins involved in primary focus and liver metastasis of human colorectal carcinomas;结直肠癌原发灶及其肝转移灶的蛋白表达差异研究
3)Hepatic metastasis肝转移癌
1.Radical Operation of Colorectal Carcinoma Plus Radiofrequency Ablation for Hepatic Metastasis at Same Stage;一期结直肠癌切除与射频消融治疗肝转移癌
4)hepatic metastasis肝脏转移
1.Expression of CDX2 protein and its significance in hepatic metastasis from colorectal carcinoma and primary hepatocellular carcinoma;尾侧型同源转录因子-2在结直肠癌肝脏转移灶和原发性肝癌中的表达及意义
2.Methods:The fresh specimens of primary cancer lesion and hepatic metastasis were collected in 5 patients suffered from colorectal cancer with liver metastasis during operation.方法:收集手术切除5例大肠癌合并肝脏转移患者的原发和转移病灶的新鲜组织标本,提取总RNA,合成荧光标记的cRNA与Agilent human 1A oligo芯片杂交。
3.The overexpression of MMP2 in normal liver tissues surrounding hepatic metastases might be correlated with the regeneration of hepatic metastasis.目的:探讨MMP2基因在大肠癌肝脏转移中的意义。
5)hepatic metastasis肝转移
1.Effect of expression of COX-2, Ki-67 and MVD on hepatic metastasis of colorectal cancer;大肠癌组织COX-2和Ki-67及MVD表达与肝转移相关性的研究
2.Effect of percutaneous chemotherapy pump placement for portal vein chemotherapy on hepatic metastasis of colorectal cancer;经皮化疗泵植入门静脉化疗治疗结直肠癌肝转移的临床观察
3.The Effect of Syndrome on Tumor s Hepatic Metastasis;血瘀状态下荷瘤小鼠肝转移的特点及相关机制研究
6)liver metastases肝转移癌
1.Objective To observe the performance of liver metastases with contrast-enhanced ultrasound(CEUS) and assess its clinical application.目的观察肝转移癌超声造影表现并探讨其临床应用价值。
2.Objective To observe the effects of percutaneous ethanol injection therapy (PEIT) for advanced liver metastases and to explore the dose of ethanol.目的 观察无水酒精瘤内注射治疗肝转移癌的疗效 ,并探讨无水酒精的用量。
3.Objective:To evaluate the feasibility and toxicity,and estimate the therapeutic effect of patients with unresectable liver metastases from colorectal carcinoma treated with three-dimensional conformal radiation therapy after TACE.结论:对于结直肠癌根治术后出现不宜或不能手术的肝转移癌,应用三维适形放疗结合TACE的治疗模式,是可行的,无严重不良反应,近期疗效显著。
延伸阅读
正常人白细胞转移因子 , 白细胞转移因子,转移因子药物名称:转移因子英文名:Transfer Factor别名: 正常人白细胞转移因子 , 白细胞转移因子,转移因子外文名:Transfer Factor ,TF适应症: 为细胞免疫反应增强剂,能将细胞免疫活性转移给受体,以提高受体的免疫功能。临床上用于治疗某些抗生素难以控制的病毒性或酶菌性细胞内感染(如带状皰疹、流行性乙型脑炎、白色念珠菌感染等)。对恶性肿瘤可作为辅助治疗剂,对自体免疫性疾病也有一定治疗作用。 用量用法: 一般采用皮下注射,注于上臂内侧或大腿内侧腹股沟下端,1次注射1支,每周1~2次,1个月后改为每2周1次。对带状疱疹,一般只需注射1次。 规格: 注射液:每支2ml,相当于1×1000000000白细胞提取物(上海产),北京产则相当于5~10×1000000000. 注:严禁静脉给药.类别:免疫调节剂
